https://www.clinicaltrialsarena.com/news/sk-bioscience-sanofi-pneumococcal-vaccine/
SK bioscience and Sanofi have reported data from the Phase II trials of GBP410, a pneumococcal conjugate vaccine candidate, in infants.
sk biosciencephase iipneumococcal vaccinesanofireport